Abstract
Disturbed redox homeostasis with both elevated reactive oxygen species (ROS) levels and antioxidant defense mechanisms has been reported in acute lymphoblastic leukemia (ALL). We therefore hypothesized that inhibition of pathways responsible for ROS detoxification renders ALL cells more susceptible for cell death. Here, we report that pharmacological inhibitors of key pathways for the elimination of ROS, i.e. Erastin, buthionine sulfoximine (BSO) and Auranofin, sensitize ALL cells for cell death upon treatment with the Smac mimetic LCL161 that antagonizes Inhibitor of Apoptosis (IAP) proteins. Erastin, BSO or Auranofin significantly increase LCL161-induced cell death and also act in concert with LCL161 to profoundly suppress long-term clonogenic survival in several ALL cell lines. Erastin or BSO cooperates with LCL161 to stimulate ROS production and lipid peroxidation prior to cell death. ROS production and lipid peroxidation are required for this cotreatment-induced cell death, since ROS scavengers or pharmacological inhibition of lipid peroxidation provides significant protection against cell death. These results emphasize that inhibition of antioxidant defense mechanisms can serve as a potent approach to prime ALL cells for ...Continue Reading
References
Apr 1, 1984·The Biochemical Journal·B Halliwell, J M Gutteridge
Jan 12, 2001·Blood·P R KearnsA G Hall
Apr 9, 2004·The New England Journal of Medicine·Ching-Hon PuiJames R Downing
Nov 22, 2005·Journal of Biochemical and Biophysical Methods·Ana GomesJosé L F C Lima
Aug 8, 2006·Oncogene·S Fulda, K-M Debatin
Nov 21, 2007·Cell·Eugene VarfolomeevDomagoj Vucic
Mar 22, 2008·Chemistry & Biology·Wan Seok Yang, Brent R Stockwell
Nov 13, 2008·International Journal of Cancer. Journal International Du Cancer·Simone Fulda
Nov 28, 2008·Blood·Melanie FaklerSimone Fulda
Dec 23, 2008·Seminars in Hematology·Martin Stanulla, Martin Schrappe
Mar 21, 2009·British Journal of Haematology·Simone Fulda
May 30, 2009·Nature Reviews. Drug Discovery·Dunyaporn TrachoothamPeng Huang
Jun 29, 2010·Pediatric Blood & Cancer·Patrick HundsdoerferGünter Henze
Dec 17, 2011·Leukemia·S LöderS Fulda
May 29, 2012·Cell·Scott J DixonBrent R Stockwell
Aug 21, 2012·Antioxidants & Redox Signaling·Mary E IrwinJoya Chandra
Nov 26, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Simone Fulda
Nov 30, 2013·Nature Reviews. Drug Discovery·Chiara GorriniTak W Mak
Feb 4, 2014·Leukemia·S Fulda
May 24, 2014·Blood·Katharina BelzSimone Fulda
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey R InfanteRoger B Cohen
Nov 11, 2014·Oncogene·H SchoenebergerS Fulda
Citations
Apr 14, 2017·Current Opinion in Hematology·Agnieszka Graczyk-JarzynkaMalgorzata Firczuk
Jul 29, 2019·Biological Chemistry·Vanessa Ehrenfeld, Simone Fulda
Jul 3, 2019·Current Gene Therapy·Xiaojun XiaPing Zhu
Feb 29, 2020·Antioxidants·Emiliano PanieriLuciano Saso
Sep 3, 2016·Oncotarget·Jasmin DächertSimone Fulda
May 23, 2020·Apoptosis : an International Journal on Programmed Cell Death·Mark A MilesChristine J Hawkins
Apr 29, 2020·Cell Death & Disease·Yongfeng ChenQiongying Hu
Jun 3, 2021·Cells·Yongfeng ChenZhiqiang Zhao
Jun 26, 2018·Journal of Medicinal Chemistry·Carlo BaggioMaurizio Pellecchia
Dec 2, 2021·Medicinal Research Reviews·Tania GamberiFrancesca Magherini